Literature DB >> 8826508

Endothelin-1 in periaqueductal gray area of mice induces analgesia via glutamatergic receptors.

M D'Amico1, L Berrino, S Maione, A Filippelli, V de Novellis, F Rossi.   

Abstract

The aim of the study was to examine whether endothelin-1 (ET-1) injected into dorsolateral periaqueductal gray (PAG) area of mice produces antinociception. ET-1, from 1 to 4 pmol/mouse, induced antinociceptive effect in a dose-dependent manner. This antinociceptive effect was prevented by NMDA receptor antagonists (2-APV and MK-801) injected in the same area (2-APV) or by intraperitoneal route (MK-801). CNQX, a non-NMDA receptor antagonist, did not inhibit the ET-1 effects. Prazosin, an alpha 1-adrenergic blocking agent, also prevented the ET-1 antinociceptive effect. We suggest that the activation of NMDA glutamatergic receptors in the PAG area may be a necessary step for ET-1 induced antinociception.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826508     DOI: 10.1016/0304-3959(95)00178-6

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  6 in total

1.  The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.

Authors:  Minxian Dai; Brandi Freeman; Fernando P Bruno; Henry J Shikani; Herbert B Tanowitz; Louis M Weiss; Sandra E Reznik; Ralph A Stephani; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2012-07-17       Impact factor: 5.037

Review 2.  Endothelin receptors and pain.

Authors:  Alla Khodorova; Jean-Pierre Montmayeur; Gary Strichartz
Journal:  J Pain       Date:  2009-01       Impact factor: 5.820

3.  Role of central endothelin-1 in hyperalgesia, anhedonia, and hypolocomotion induced by endotoxin in male rats.

Authors:  Luís Alexandre Lomba; Juliana Varella Cruz; Letícia Costa Mastrangelo Coelho; Mariane Cristina Guttervill Leite-Avalca; Diego Correia; Aleksander Roberto Zampronio
Journal:  Exp Brain Res       Date:  2020-11-04       Impact factor: 1.972

4.  Effects of repeated central administration of endothelin type A receptor antagonist on the development of neuropathic pain in rats.

Authors:  Lydia W Tai; Victor K L Hung; Wei Mei; Qiu Qiu; Sookja K Chung; C W Cheung
Journal:  Biomed Res Int       Date:  2013-08-29       Impact factor: 3.411

5.  A role of periaqueductal grey NR2B-containing NMDA receptor in mediating persistent inflammatory pain.

Authors:  Jing Hu; Zhe Wang; Yan-Yan Guo; Xiao-Nan Zhang; Zhao-Hui Xu; Shui-Bing Liu; Hong-Ju Guo; Qi Yang; Fu-Xing Zhang; Xiao-Li Sun; Ming-Gao Zhao
Journal:  Mol Pain       Date:  2009-12-12       Impact factor: 3.395

Review 6.  Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain.

Authors:  Terika P Smith; Tami Haymond; Sherika N Smith; Sarah M Sweitzer
Journal:  J Pain Res       Date:  2014-08-30       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.